Bay, S. B. Et Al. 2019. Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6 , 1343-1348.

Bay, S. B., Kebudi, R., Gorgun, O., Zulfikar, B., Darendeliler, E., & ÇAKIR, F. B., (2019). Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, 1343-1348.

Bay, Sema Et Al. "Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, 1343-1348, 2019

Bay, Sema B. Et Al. "Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, pp.1343-1348, 2019

Bay, S. B. Et Al. (2019) . "Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.6, pp.1343-1348.

@article{article, author={Sema Bueyukkapu Bay Et Al. }, title={Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2019, pages={1343-1348} }